Quantum-Si Incorporated, The Protein Sequencing CompanyTM, announced that it will be participating in the Jefferies Healthcare Conference taking place at the Marriott Marquis, New York, NY on June 7-9, 2023.
BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the Jefferies Healthcare Conference taking place at the Marriott Marquis, New York, NY on June 7-9, 2023.
Quantum-Si’s management will present on Thursday, June 8, 2023 at 8:30 AM ET.
A live and archived webcast of the event will be available in the Investors section of the Quantum-Si website under Events & Presentations.
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing CompanyTM, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230525005333/en/
Investor Contact
Juan Avendano
ir@quantum-si.com
Media Contact
Michael Sullivan
media@quantum-si.com
Source: Quantum-Si Incorporated
View this news release online at:
http://www.businesswire.com/news/home/20230525005333/en
